15.3 Advanced Cardiovascular Life Support (ACLS) in the Perioperative Environment

15.3 Advanced Cardiovascular Life Support (ACLS) in the Perioperative Environment

Cardiac arrest in the operating room and procedural suites represents a distinct clinical entity compared to out-of-hospital or general inpatient ward arrests. In the perioperative setting, the patient is continuously instrumented with physiological monitors (continuous electrocardiography, pulse oximetry, capnography, invasive arterial blood pressure lines), has immediate pre-existing intravenous or central access, and is under the direct physical care of trained anesthesia and surgical personnel. Consequently, perioperative cardiac arrest is witnessed instantly, allowing resuscitation to commence within seconds. However, the etiologies of intraoperative arrest are heavily weighted toward acute surgical hemorrhage, anesthetic overdose, autonomic reflexes, metabolic shifts, and unique drug toxicities that demand specialized adaptations to standard American Heart Association (AHA) Advanced Cardiovascular Life Support (ACLS) guidelines.

---

The Expanded 5 H's & 5 T's in the Operating Room

Resuscitation in the operating room hinges upon rapid identification and aggressive reversal of underlying pathophysiological triggers. These etiologies are structured around the classic framework of the 5 H's and 5 T's, adapted specifically to the surgical and anesthetic theater:

+-----------------------------------------------------------------------------+
|               PERIOPERATIVE 5 H'S AND 5 T'S ARREST FRAMEWORK                |
+-----------------------------------------------------------------------------+
| ETIOLOGY            | PERIOPERATIVE MECHANISM & TARGETED RESCUE             |
+---------------------+-------------------------------------------------------+
| Hypovolemia         | Catastrophic surgical hemorrhage (vascular injury,    |
|                     | aneurysm rupture). Target: Rapid blood transfusions.  |
+---------------------+-------------------------------------------------------+
| Hypoxia             | Airway disconnect, tube kink, mucus plug, spasm.      |
|                     | Target: Hand ventilation with 100% FiO2.              |
+---------------------+-------------------------------------------------------+
| Hydrogen Ion        | Severe metabolic acidosis (hypoperfusion) or          |
| (Acidosis)          | hypercarbic respiratory acidosis. Target: Buffers/vent|
+---------------------+-------------------------------------------------------+
| Hypo / Hyperkalemia | Massive PRBC transfusion (aged blood) or succinyl-    |
|                     | choline in denervation/burns. Target: Calcium, insulin|
+---------------------+-------------------------------------------------------+
| Hypothermia         | Cold fluids, open cavities, cold OR. Target: Inline   |
|                     | fluid warmers, forced-air blankets, warm irrigations. |
+---------------------+-------------------------------------------------------+
| Tension Pneumo-     | Barotrauma, CVC placement, diaphragmatic tears.       |
| thorax              | Target: Immediate needle decompression / chest tube.  |
+---------------------+-------------------------------------------------------+
| Tamponade (Cardiac) | Penetrating injury, CVC cardiac perforation, sternal  |
|                     | wires. Target: Emergency pericardiocentesis / window. |
+---------------------+-------------------------------------------------------+
| Toxins              | LAST (bupivacaine), MH (volatile/succinylcholine),    |
|                     | BCIS (bone cement). Target: Lipids, Dantrolene, press.|
+---------------------+-------------------------------------------------------+
| Thrombosis (Pulm/   | Massive pulmonary thromboembolism (PE) or massive     |
| Gas Embolism)       | venous gas/CO2 embolism. Target: Durant's, vent gas.  |
+---------------------+-------------------------------------------------------+
| Thrombosis (Coronary| Perioperative acute myocardial infarction (Type 1 or  |
| / Acute MI)         | Type 2 supply-demand). Target: Coronary perfusion.    |
+-----------------------------------------------------------------------------+

Clinical Details of Perioperative Triggers

1. Hypovolemia: A leading cause of intraoperative arrest. Caused by sudden major vascular disruption (e.g., iliac artery laceration, retroperitoneal hematoma, ruptured visceral aneurysm). Arterial line tracings demonstrate severe systolic pressure variation (marked respiratory pulse pressure variation) and acute hypotension progressing rapidly to pulseless electrical activity (PEA).
2. Hypoxia: Mechanical breathing circuit failure, pipeline disconnection, accidental extubation, unrecognized endobronchial intubation, mucus plugging, or complete laryngospasm. The earliest sign is a sudden loss of the capnography plateau followed by a precipitous drop in SpO₂ and profound hypoxemic bradycardia.
3. Hyperkalemia: Stored packed red blood cells (PRBCs) undergo progressive potassium leakage; units stored near their 42-day expiration limit can contain extracellular potassium concentrations exceeding 30 to 50 mEq/L. Rapid massive transfusion, reperfusion of ischemic limbs following vascular declamping, or succinylcholine administration to patients with extensive thermal burns or denervating spinal cord injuries triggers explosive hyperkalemia. Manifests on ECG as tall, peaked T-waves, PR prolongation, widening of the QRS complex into a sinusoidal wave, and sudden ventricular fibrillation or asystole.
4. Tension Pneumothorax: Arises during central venous cannulation (subclavian/internal jugular vein puncture), thoracic trauma, or high airway pressures in patients with bullous emphysema. Manifests as a sudden rise in peak inspiratory pressure, unilateral absence of breath sounds, tracheal deviation (a late sign), and PEA arrest from impaired venous return.
5. Vagal Reflexes & Surgical Retraction: Intense surgical traction on the peritoneum, mesenteric traction, ocular muscle traction (oculocardiac reflex via CN V to CN X), or direct manipulation of the carotid sinus can trigger catastrophic vagal bradycardia and sinus arrest. Immediate management requires demanding the surgeon halt surgical traction and administering intravenous anticholinergics (for example, glycopyrrolate 0.2-0.4 mg or atropine 0.4-1 mg).

---

Defibrillation Protocols: Shockable Rhythms (VF / pVT)

Ventricular Fibrillation (VF) and Pulseless Ventricular Tachycardia (pVT) are shockable rhythms. Survival is highest when defibrillation is delivered within the first few minutes of VF or pulseless VT.

+-----------------------------------------------------------------------------+
|                 SHOCKABLE RHYTHM (VF / PULSELESS VT) ALGORITHM              |
+-----------------------------------------------------------------------------+
                                      |
                                      v
                         VERIFY VF / PULSELESS VT
         - Call for Code Cart & Defibrillator.
         - Initiate immediate high-quality chest compressions.
                                      |
                                      v
                   DELIVER DEFIBRILLATION SHOCK #1
         - Biphasic: manufacturer dose (often 120-200 J); if unknown, use max.
         - Monophasic (historical): 360 Joules.
         - Ensure "SYNC" is turned OFF (Unsynchronized mode!).
                                      |
                                      v
                 RESUME CPR IMMEDIATELY FOR 2 MINUTES!
         - DO NOT PAUSE TO CHECK RHYTHM OR PULSE!
         - High-quality compressions: 100-120/min, 2-2.4 inches depth.
         - Advanced airway: 1 breath q6 seconds (avoid hyperventilation).
                                      |
                                      v
                            RHYTHM CHECK (2 min)
         - If persistent VF/pVT -> DELIVER SHOCK #2 (Equal/Escalating J).
         - Resume CPR immediately for 2 minutes.
         - DRUG: EPINEPHRINE 1 mg IV/IO (repeat every 3 to 5 minutes).
                                      |
                                      v
                            RHYTHM CHECK (4 min)
         - If persistent VF/pVT -> DELIVER SHOCK #3.
         - Resume CPR immediately for 2 minutes.
         - DRUG: AMIODARONE 300 mg IV/IO bolus (First Dose)
           [Alternative: Lidocaine 1.0 - 1.5 mg/kg IV/IO].
                                      |
                                      v
                            RHYTHM CHECK (6 min)
         - If persistent VF/pVT -> DELIVER SHOCK #4.
         - Resume CPR immediately for 2 minutes.
         - DRUG: AMIODARONE 150 mg IV/IO bolus (Second Dose)
           [Alternative: Lidocaine 0.5 - 0.75 mg/kg IV/IO].

Defibrillator Operation Rules

1. Unsynchronized Delivery: Ensure the defibrillator is in DEFIB (unsynchronized) mode. If the "SYNC" button is accidentally engaged, the machine waits for an R wave so it can time the shock away from the vulnerable T wave; because VF has no organized QRS complexes, the shock may not fire.
2. Multifunction Pad Placement: Apply adhesive multifunction defibrillator pads firmly to clean, dry skin. The standard configuration is Anterior-Lateral (one pad below the right clavicle lateral to the sternum; one pad mid-axillary at the fifth intercostal space over the cardiac apex). Ensure pads are clear of surgical drapes, fluid pools, and sternal incisions.
3. Immediate Resumption of CPR: Immediately upon shock discharge, compressions must resume without pausing to palpate for a pulse or analyze the rhythm. The post-shock myocardium remains electrophysiologically stunned; pausing compressions produces profound myocardial ischemia. Rhythm and pulse analysis occurs strictly at the conclusion of each 2-minute CPR cycle.

---

Non-Shockable Rhythms: Asystole & Pulseless Electrical Activity (PEA)

Non-shockable rhythms are common initial arrest rhythms in surgical patients, predominantly triggered by hypovolemia, hypoxia, tension pneumothorax, or severe acidosis.

• Pulseless Electrical Activity (PEA): Characterized by an organized electrical rhythm on the ECG monitor that fails to produce a detectable mechanical arterial pulse or blood pressure.
• Asystole: The complete absence of ventricular electrical and mechanical activity (flatline).

Critical Protocol Imperatives

• NO DEFIBRILLATION: Shocks do not treat PEA or asystole and only interrupt compressions.
• Continuous High-Quality CPR: Initiate compressions immediately.
• Early Epinephrine: Administer Epinephrine 1 mg IV/IO as early as possible and repeat every 3 to 5 minutes.
• Immediate Surgical Diagnostics: The team must aggressively evaluate surgical triggers:
  • Has the surgeon lacerated a major vein or artery? (Check operative field / suction canisters).
  • Is there excessive intra-abdominal insufflation pressure? (Demand release of pneumoperitoneum).
  • Are surgical retractors compressing the inferior vena cava? (Release abdominal wall or sternal retractors).
  • Is there an acute tension pneumothorax? (Perform needle thoracostomy if breath sounds are absent or peak pressures soared).

---

High-Quality CPR Metrics & Quantitative Capnography

The quality of manual closed-chest compressions is the single most critical determinant of coronary and cerebral perfusion pressure during cardiac arrest.

+-----------------------------------------------------------------------------+
|                     HIGH-QUALITY CHEST COMPRESSION METRICS                  |
+-----------------------------------------------------------------------------+
| Parameter                  | Target Standard                                |
+----------------------------+------------------------------------------------+
| Compression Rate           | 100 to 120 compressions per minute             |
+----------------------------+------------------------------------------------+
| Compression Depth          | 2.0 to 2.4 inches (5 to 6 cm) in adults        |
+----------------------------+------------------------------------------------+
| Chest Wall Recoil          | Allow COMPLETE recoil; do NOT lean on chest    |
+----------------------------+------------------------------------------------+
| Interruptions              | Minimize hands-off time (< 10 seconds per pause|
+----------------------------+------------------------------------------------+
| Compressor Rotation        | Switch compressors every 2 minutes to prevent  |
|                            | physical fatigue and compression degradation   |
+----------------------------+------------------------------------------------+
| Ventilation (With ETT)     | 1 breath every 6 seconds (10 breaths/min);     |
|                            | AVOID HYPERVENTILATION!                        |
+-----------------------------------------------------------------------------+

The Lethal Harm of Hyperventilation

During CPR, cardiac output generated by chest compressions is only 25% to 33% of normal resting output. Therefore, physiological pulmonary ventilation requirements are drastically reduced. Delivering excessive respiratory rates (> 12-15 breaths/min) or large tidal volumes produces catastrophic consequences:

• Elevates mean intrathoracic pressure, collapsing the vena cava and severely impeding venous return (preload) to the right atrium.
• Directly reduces Coronary Perfusion Pressure (CPP = Diastolic Aortic Pressure - Right Atrial Diastolic Pressure), preventing myocardial resuscitation.
• Induces cerebral vasoconstriction via hypocapnia, severely reducing cerebral blood flow.

End-Tidal Carbon Dioxide (PetCO2) as a Resuscitation Biomarker

In intubated patients undergoing CPR, continuous quantitative capnography provides an objective, real-time physiological measurement of pulmonary blood flow and cardiac output generated by chest compressions:

                        END-TIDAL CO2 (PetCO2) DURING CPR

    PetCO2 (mmHg)
     ^
  50 |
  40 |--------------------------------------[ ROSC JUMP: PetCO2 >= 35-40 mmHg ]
     |                                      (Sudden sustained surge in cardiac
  30 |                                       output from beating heart!)
     |-------------------
  20 | [ CPR TARGET: PetCO2 >= 20 mmHg ]
     |-------------------
  10 |--------------------------------------[ POOR CPR: PetCO2 < 10 mmHg ]
     |                                      (Ineffective compressions / fatigue;
   0 +------------------------------------>  re-evaluate depth, rate, recoil)
       Time (minutes)

1. Inadequate CPR Quality (PetCO₂ < 10 mmHg): Indicates that compressions are generating inadequate cardiac output. If PetCO₂ remains below 10 mmHg, compressions must be immediately re-evaluated: increase depth, optimize rate, ensure complete chest recoil, and rotate compressors.
2. Higher Values (often about 20 mmHg or more): Suggest more effective compressions. AHA guidance emphasizes reassessing CPR quality whenever PetCO2 is low or falling.
3. Return of Spontaneous Circulation (ROSC) Hallmark: A sudden, sustained jump in PetCO₂ (typically rocketing from 10-15 mmHg up to 35 to 40 mmHg or greater) is an early, reliable physiological indicator of ROSC. As the heart resumes spontaneous, forceful contractions, cardiac output surges, transporting accumulated tissue carbon dioxide to the lungs for elimination. Compressions should be paused to verify a palpable pulse and arterial line waveform.

---

Specialized Perioperative Resuscitation Scenarios

Standard ACLS protocols must be substantially modified during specialized perioperative crises.

1. Local Anesthetic Systemic Toxicity (LAST)

• Mechanism: Accidental direct intravascular injection or rapid systemic vascular absorption of potent local anesthetics (e.g., bupivacaine, ropivacaine) during regional blocks. Local anesthetics block voltage-gated cardiac sodium channels, uncoupling excitation-contraction mechanisms, precipitating intractable conduction blocks, ventricular arrhythmias, and myocardial depression.
• Modified ACLS Sequence:
  1. Stop local anesthetic injection immediately; call for the LAST Rescue Kit and 20% Lipid Emulsion.
  2. Airway Management: Administer 100% FiO₂; ventilate to avoid hypoxemia, hypercarbia, and acidosis, which worsen bupivacaine toxicity.
  3. Lipid Emulsion (Intralipid 20%) Administration:
     • Initial IV Bolus: Over 70 kg, 100 mL over 2 to 3 minutes; under 70 kg, 1.5 mL/kg over 2 to 3 minutes.
     • Continuous IV Infusion: Over 70 kg, 200 to 250 mL over 15 to 20 minutes; under 70 kg, about 0.25 mL/kg/min (ideal body weight).
     • Refractory Collapse: If cardiovascular stability is not restored, repeat the bolus once or twice and double the infusion rate to 0.5 mL/kg/min.
     • Dose Limit: About 12 mL/kg is the recommended upper limit for initial dosing.
  4. CRITICAL PHARMACOLOGIC MODIFICATIONS:
     • Reduce Epinephrine Boluses: Administer small doses of < 1 mcg/kg (e.g., 10 to 100 mcg IV boluses) rather than standard 1 mg doses. Standard 1 mg doses can worsen arrhythmias and outcomes in LAST.
     • AVOID VASOPRESSIN: The ASRA LAST checklist advises against vasopressin.
     • AVOID CALCIUM CHANNEL BLOCKERS & BETA-BLOCKERS: Potentiate myocardial suppression.
     • AVOID LOCAL ANESTHETIC ANTIARRHYTHMICS: Avoid lidocaine and procainamide.

2. Malignant Hyperthermia (MH) Crisis

• Mechanism: Pharmacogenetic excitation of abnormal Ryanodine receptor 1 (RYR1) channels in skeletal muscle sarcoplasmic reticulum triggered by volatile inhalational anesthetics (sevoflurane, desflurane, isoflurane) or succinylcholine.
• Pathophysiology: Uncontrolled intracellular calcium surge triggers hypermetabolism, sustained generalized muscle rigidity, rapidly rising PetCO2 despite increased ventilation, mixed metabolic-respiratory acidosis, rhabdomyolysis, hyperthermia (often a later sign), and explosive hyperkalemia leading to sudden PEA or VF cardiac arrest.
• Protocol:
  1. Immediately halt all volatile anesthetics and succinylcholine.
  2. Hyperventilate with 100% FiO₂ at ≥ 10 L/min using activated charcoal vapor filters (Vapor-Clean) placed on the inspiratory and expiratory limbs.
  3. Administer Dantrolene Sodium: Initial dose 2.5 mg/kg IV rapidly, repeated as needed until signs resolve (more than 10 mg/kg is occasionally required) (Ryanodex formulation: 250 mg reconstitutes in 5 mL sterile water; standard dantrolene: 20 mg per vial, each requiring 60 mL sterile water).
  4. Treat Life-Threatening Hyperkalemia: Administer Calcium Chloride (10 mg/kg IV; 1 g in adults) to stabilize myocardial membranes, followed by Regular Insulin (10 units IV) + 50% Dextrose (50 mL IV), and Sodium Bicarbonate (1-2 mEq/kg IV).

3. Bone Cement Implantation Syndrome (BCIS)

• Mechanism: Pressurization of methylmethacrylate (MMA) bone cement into the femoral canal during cemented arthroplasty forces bone marrow fat, micro-emboli, and methylmethacrylate monomer into the venous circulation.
• Presentation: Sudden pulmonary hypertension, acute right ventricular failure, massive shunt, severe hypotension, and sudden cardiac arrest.
• Treatment: Pre-emptively administer 100% FiO₂, aggressive volume loading, and vasopressors (phenylephrine or norepinephrine, with epinephrine for severe collapse).

---

The Anesthesia Technologist's Tactical Role During a Code

During an intraoperative code, the anesthesia technologist is an indispensable resuscitation team member whose rapid, precise technical execution directly influences survival:

+-----------------------------------------------------------------------------+
|             TECHNOLOGIST TACTICAL RESPONSIBILITIES IN A CODE                |
+-----------------------------------------------------------------------------+
| Operational Domain         | Specific Technical Interventions               |
+----------------------------+------------------------------------------------+
| Defibrillator & CPR        | - Mobilize code cart & defibrillator to bedside|
|                            | - Apply multifunction pads; ensure proper lead |
|                            |   configuration (Anterior-Lateral).            |
|                            | - Perform high-quality chest compressions.     |
+----------------------------+------------------------------------------------+
| Rapid Infusion Deployment  | - Set up & prime rapid infuser (Belmont/Level1)|
|                            | - Purge all micro-bubbles from disposable lines|
|                            | - Spike uncrossmatched O-negative PRBCs/fluid. |
|                            | - Confirm warming is on; infuse on command.    |
+----------------------------+------------------------------------------------+
| Emergency Drug Reconsti-   | - Retrieve prefilled ACLS drug syringes and    |
| tution & Preparation       |   supplies for the provider: epinephrine,      |
|                            |   amiodarone, calcium, bicarbonate, atropine.  |
|                            | - Bring 20% lipid emulsion if LAST.            |
|                            | - Help mix dantrolene if MH (per policy).      |
+----------------------------+------------------------------------------------+
| Point-of-Care Blood Gas &  | - Draw arterial samples per facility policy.   |
| Laboratory Sampling        | - Run point-of-care cartridge (i-STAT / ABL).  |
|                            | - Verbally announce critical values (pH, K+,   |
|                            |   Hct, Base Deficit) clearly to team leader.   |
+-----------------------------------------------------------------------------+

By ensuring rapid fluid delivery, accurate drug preparation, high-quality chest compressions, and precise physiological monitoring, the Certified Anesthesia Technologist functions as the operational backbone of perioperative resuscitation.